Apoptosis signaling

被引:1327
作者
Strasser, A [1 ]
O'Connor, L
Dixit, VM
机构
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[2] Genentech Inc, San Francisco, CA 94080 USA
关键词
cell death; bcl-2 protein family; tumor necrosis factor receptor family; cysteine proteases; development;
D O I
10.1146/annurev.biochem.69.1.217
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Apoptosis, a physiological process for killing cells, is critical for the normal development and function of multicellular organisms. Abnormalities in cell death control can contribute to a variety of diseases, including cancer, autoimmunity, and degenerative disorders. Signaling for apoptosis occurs through multiple independent pathways that are initiated either from triggering events within the cell or from outside the cell, for instance, by ligation of death receptors. All apoptosis signaling pathways converge on a common machinery of cell destruction that is activated by a family of cysteine proteases (caspases) that cleave proteins at aspartate residues. Dismantling and removal of doomed cells is accomplished by proteolysis of vital cellular constituents, DNA degradation, and phagocytosis by neighboring cells. This article reviews current knowledge of apoptosis signaling, lists several pressing questions, and presents a novel model to explain the biochemical and functional interactions between components of the cell death regulatory machinery.
引用
收藏
页码:217 / 245
页数:29
相关论文
共 289 条
[1]
Acton D, 1992, Curr Top Microbiol Immunol, V182, P293
[2]
TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER [J].
ADACHI, M ;
SUEMATSU, S ;
KONDO, T ;
OGASAWARA, J ;
TANAKA, T ;
YOSHIDA, N ;
NAGATA, S .
NATURE GENETICS, 1995, 11 (03) :294-300
[3]
The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[4]
Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: Evidence for a protease-dependent pathway that does not activate cysteine protease P32 [J].
Adjei, PN ;
Kaufmann, SH ;
Leung, WY ;
Mao, F ;
Gores, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) :2588-2596
[5]
Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice [J].
Akashi, K ;
Kondo, M ;
vonFreedenJeffry, U ;
Murray, R ;
Weissman, IL .
CELL, 1997, 89 (07) :1033-1041
[6]
Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[7]
Inhibition of Bax channel-forming activity by Bcl-2 [J].
Antonsson, B ;
Conti, F ;
Ciavatta, A ;
Montessuit, S ;
Lewis, S ;
Martinou, I ;
Bernasconi, L ;
Bernard, A ;
Mermod, JJ ;
Mazzei, G ;
Maundrell, K ;
Gambale, F ;
Sadoul, R ;
Martinou, JC .
SCIENCE, 1997, 277 (5324) :370-372
[8]
Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[9]
CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18 [J].
BAKHSHI, A ;
JENSEN, JP ;
GOLDMAN, P ;
WRIGHT, JJ ;
MCBRIDE, OW ;
EPSTEIN, AL ;
KORSMEYER, SJ .
CELL, 1985, 41 (03) :899-906
[10]
BARR PJ, 1994, BIO-TECHNOL, V12, P487, DOI 10.1038/nbt0594-487